Autopsy report · NCT03293888
Spectral Analysis Probe to Identify Glioblastoma Cells
Cause of deathStaffing, sites or logistics
“PI Relocation”
Life of this trial
- Registered 2 months before it started.
- Ran for about 11 months before it stopped.
- 12 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- University of Oklahoma
- Sponsor type
- University, hospital or other
- Conditions
- Glioblastoma
- Participants
- 12
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
“PI relocated to another Institution” - Isoflurane-induced Neuroinflammation in Children With Hydrocephalus
“PI moving to another institution.” - International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
“PI moving on from current institution” - Effects of Sustained Reading on the Ocular Surface
“PI is moving to a different institution.” - ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
“PI is in process of transferring to a new institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.